Apostrophe, a skin care telehealth brand headquartered in the Bay Area, is shutting down after almost four years under the ...
Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on ...
Hims & Hers Health (NYSE:HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A message ...
Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operation | Hims & Hers ...
Changes are afoot in the teledermatology space. As Hims & Hers shutters Apostrophe, the teledermatology specialist it ...
A view of the Hims smartphone app. Photo: Getty Images Hims & Hers Health will shut down Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is ...
On Friday, the telehealth company discontinued Apostrophe, the direct-to-consumer skincare startup that it bought in 2021 for $190 million. According to a message on Apostrophe's website ...
Who else would you like to hear that has an apostrophe in their name? We'll spin a set. Hear your requests weekdays after 9 a.m. Today's set: Gilbert O'Sullivan "Alone Again (Naturally)" 'Til ...
Hims & Hers Health has called time on Apostrophe, its personalised acne treatments business. The San Francisco-based ...
Hims & Hers Health (HIMS) has disclosed plans to shut down Apostrophe, its acne treatment business. This change is part of ...
(Reuters) -Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being shut down to "simplify its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results